https://ntp.niehs.nih.gov/go/6249

Target Organs and Levels of Evidence for TR-469

Toxicology and Carcinogenesis Studies of AZT (CASRN 30516-87-1) and AZT/ a-Interferon A/D B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
3'-Azido-3'-deoxythymidine (AIDS)
30516-87-1		 12/11/1996 Gavage
MICE ONLY: 0, 30, 60, OR 120 MG/KG; 50/SEX		 Southern Research Institute

Levels of Evidence

Male Mice: Equivocal Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 0/50 0/48 0/49 3/50 OR CARCINOMA 0/50 0/48 0/49 1/50 COMBINED 0/50 0/48 0/49 4/50
  • Harderian Gland: ADENOMA 3/33 2/50 2/50 10/46 OR CARCINOMA 0/33 3/50 2/50 0/46 COMBINED 3/33 5/50 2/50 10/46
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Vagina: SQUAMOUS CELL CARCINOMA 0/50 0/50 5/50 9/50; SQUAMOUS CELL PAPILLOMA OR CARCINOMA 0/50 0/50 5/50 11/50
Non-Neoplastic Lesions
  • Vagina: EPITHELIAL HYPERPLASIA
 
Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Interferon AD (AIDS Initiative)
INTERFERONAD		 12/11/1996 Subcutaneous Injection
MICE ONLY: 500 OR 5000 UNITS 3X/WEEK; 50/SEX/GROUP		 Southern Research Institute

Levels of Evidence: None

 
Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Interferon AD + 3'-azido-3'-deoxythymidine (AIDS Initiative)
INTAZTCOMB		 12/11/1996 Subcutaneous Injection and Gavage
DUAL ROUTES WITH BOTH COMPOUNDS: AZT: 0, 30, 60, OR 120 (GAV) MG/KG; IFN: 500 OR 5000 UNITS 3X/WEEK		 Southern Research Institute

Levels of Evidence: None

 
Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Interferon A (AIDS Initiative)
76543-88-9		 12/11/1996 Subcutaneous Injection
5000 UNITS 3X A WEEK; 50/SEX/GROUP		 Southern Research Institute

Levels of Evidence: None